Company Filing History:
4 out of 24 
1 out of 290 
1 out of 119 Years Active: 2021-2024
Title: Gunther Roland Galler: Innovator in Antibody Therapeutics
Introduction
Gunther Roland Galler is a notable inventor based in Jyllinge, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of antibody therapies. With a total of six patents to his name, Galler's work focuses on innovative solutions for treating diseases related to immune system modulation.
Latest Patents
Galler's latest patents include groundbreaking inventions such as anti-PD-1 antibodies and compositions. This invention relates to anti-PD-1 antibodies and methods of using them in treating diseases and conditions associated with PD-1 activity, including cancer. Another significant patent is for anti-LAG-3 antibodies and compositions, which pertains to methods of using these antibodies in treating diseases that benefit from modulating LAG-3 activity, also relevant in cancer treatment.
Career Highlights
Throughout his career, Galler has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Symphogen A/S and Les Laboratoires Servier. His work in these organizations has contributed to advancements in therapeutic antibody development.
Collaborations
Galler has collaborated with esteemed professionals in his field, including Thomas Bouquin and Ivan David Horak. These collaborations have further enhanced his research and development efforts in antibody therapeutics.
Conclusion
Gunther Roland Galler is a distinguished inventor whose work in antibody therapies has the potential to impact cancer treatment significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.